D'Costa M, Angel A
Can J Physiol Pharmacol. 1975 Aug;53(4):603-9. doi: 10.1139/y75-084.
The initial rate of net glycerol release in norepinephrine-stimulated adipose tissue fragments was inhibited (40-78%) by procaine-HCl (1-5mM), whereas basal (unstimulated) lipolysis was unaffected. A dose-related inhibition of norepinephrine-induced lipolysis by procaine-HCl (0.1-1 mM) also occurred in adipocytes. Procaine-induced antilipolysis was associated with an augmented rather than a reduced hormone-stimulated increment in intracellular cyclic AMP. The dissociation of lipolysis from cyclic AMP accumulation has been termed the uncoupling effect of procaine. This effect of procaine was employed to define the precise mechanism of action of the antilipolytic drug clofibrate (Atromid-S) which inhibits lipolysis by reducing cyclic AMP. A reduction in cyclic AMP by clofibrate was demonstrated in norepinephrine-stimulated cells exposed to procaine (uncoupled system). Thus, the inhibitory effect of clofibrate on cyclic AMP could not be attributed to accumulation of products of lipolysis. Because neither procaine-HCl nor clofibrate had any effect on the low Km 3':5'-cyclic-AMP phosphodiesterase (EC 3.1.4.17) activity in hormone stimulated cells, the clofibrate-induced reduction in cyclic AMP was attributed to its direct action on adipocyte adenylate cyclase.
在去甲肾上腺素刺激的脂肪组织碎片中,盐酸普鲁卡因(1-5mM)可抑制甘油净释放的初始速率(40-78%),而基础(未刺激)脂解不受影响。在脂肪细胞中,盐酸普鲁卡因(0.1-1 mM)也会对去甲肾上腺素诱导的脂解产生剂量相关的抑制作用。普鲁卡因诱导的抗脂解作用与激素刺激的细胞内环磷酸腺苷(cAMP)增加而非减少有关。脂解与cAMP积累的解离被称为普鲁卡因的解偶联效应。利用普鲁卡因的这种效应来确定抗脂解药物氯贝丁酯(安妥明)的精确作用机制,氯贝丁酯通过减少cAMP来抑制脂解。在暴露于普鲁卡因的去甲肾上腺素刺激细胞(解偶联系统)中,证明氯贝丁酯可降低cAMP。因此,氯贝丁酯对cAMP的抑制作用不能归因于脂解产物的积累。由于盐酸普鲁卡因和氯贝丁酯对激素刺激细胞中的低Km 3':5'-环磷酸腺苷磷酸二酯酶(EC 3.1.4.17)活性均无任何影响,氯贝丁酯诱导的cAMP降低归因于其对脂肪细胞腺苷酸环化酶的直接作用。